Atherectomy for Superficial Femoral Artery In-Stent Restenosis: Can Lasers Light the Way to a Better Outcome?

Norgren L Hiatt WR Dormandy JA Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1–75

Schillinger M Sabeti S Dick P Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745–2749

Krankenberg H Schluter M Steinkamp HJ Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285–292

Laird JR Katzen BT Scheinert D Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267–276

Schillinger M Sabeti S Loewe C Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879–1888

Soga Y Iida O Hirano K Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg. 2011;54:1058–1066

Dake MD Ansel GM Jaff MR Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions. J Am Coll Cardiol. 2013;61:2417–2427

Tosaka A Soga Y Iida O Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59:16–23

Gandini R Del Giudice C Assako Ondo EP Stent puncture for recanalization of occluded superficial femoral artery stents. J Endovasc Ther. 2012;19:30–33

Dick P Sabeti S Mlekusch W Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology. 2008;248:297–302

Trentmann J Charalambous N Djawanscher M Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg (Torino). 2010;51:551–560

Shammas NW Shammas GA Helou TJ Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med. 2012;13:224–227

Zeller T Rastan A Sixt S Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol. 2006;48:1573–1578

Yeo KK Malik U Laird JR. Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience. Catheter Cardiovasc Interv. 2011;78:604–608

Shammas NW Shammas GA Hafez A Safety and one-year revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med. 2012;13:341–344

Schmidt A Zeller T Sievert H Photoablation using the Turbo-Booster and excimer laser for in-stent restenosis treatment: twelvemonth results from the PATENT study. J Endovasc Ther. 2014;21:52–60

Gandini R Del Giudice C Merolla S Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther. 2013;20:805–814.